Citius Oncology, Inc. (CTOR) is a biopharmaceutical company headquartered in Cranford, New Jersey, focused on developing and commercializing targeted oncology therapies. Its lead product is LYMPHIR (denileukin diftitox-cdxl), an engineered IL-2 diphtheria toxin fusion protein approved by the FDA in August 2024 for persistent or recurrent cutaneous T-cell lymphoma (CTCL), a rare non-Hodgkin lymphoma. The company targets a market estimated to exceed $400 million and commercializes products independently in the U.S. while partnering for international markets.
Q2 FY2026 — expected 2026-09-14
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-12-23 | 2025-09-30 | 0001213900-25-125331 | EDGAR | 61K words |
| 2024-12-27 | 2024-09-30 | 0001213900-24-113150 | EDGAR | 47K words |
| 2024-04-16 | 2023-12-31 | 0001493152-24-014850 | EDGAR | 38K words |
| 2023-04-17 | 2022-12-31 | 0001493152-23-012545 | EDGAR | 33K words |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-14 | 2026-06-30 | 0001213900-26-090184 | EDGAR | 21K words |
| 2026-02-13 | 2025-12-31 | 0001213900-26-015877 | EDGAR | 15K words |
| 2025-08-12 | 2025-06-30 | 0001213900-25-074992 | EDGAR | 14K words |
| 2025-05-14 | 2025-03-31 | 0001213900-25-043359 | EDGAR | 13K words |
| 2025-02-14 | 2024-12-31 | 0001213900-25-014320 | EDGAR | 10K words |
| 2024-08-09 | 2024-06-30 | 0001493152-24-030991 | EDGAR | 17K words |
| 2024-05-20 | 2024-03-31 | 0001493152-24-020783 | EDGAR | 16K words |
| 2023-11-20 | 2023-09-30 | 0001493152-23-042170 | EDGAR | 16K words |
| 2023-08-16 | 2023-06-30 | 0001493152-23-029131 | EDGAR | 15K words |
| 2023-05-15 | 2023-03-31 | 0001493152-23-017394 | EDGAR | 14K words |
| 2022-11-28 | 2022-09-30 | 0001493152-22-033847 | EDGAR | 13K words |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-09-29 | 0001213900-26-104694 | EDGAR | 1K words |
| 2026-08-14 | 0001213900-26-090182 | EDGAR | 4K words |
| 2026-08-12 | 0001213900-26-088068 | EDGAR | 1K words |
| 2026-08-05 | 0001213900-26-085434 | EDGAR | 2K words |
| 2026-03-31 | 0001213900-26-037501 | EDGAR | 3K words |
| 2026-03-10 | 0001213900-26-025464 | EDGAR | 3K words |
| 2026-03-04 | 0001213900-26-023440 | EDGAR | 3K words |
| 2026-02-13 | 0001213900-26-015894 | EDGAR | 3K words |
| 2025-12-23 | 0001213900-25-125418 | EDGAR | 3K words |
| 2025-12-10 | 0001213900-25-120197 | EDGAR | 2K words |
80 total filings indexed. 55 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001851484 |
| Ticker | CTOR |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Headquarters | Cranford, New Jersey |
| Website | https://www.citiusonc.com |
| Listed | 2024-08-13 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/CTOR (~200 tokens, structured JSON with cryptographic provenance)